Vericel (VCEL) Operating Leases (2019 - 2026)
Vericel's (VCEL) quarterly Operating Leases came in at $95.0 million in Q1 2026, up 8.24% year-on-year from $87.8 million in Q1 2025, and up 15.5% quarter-over-quarter from $82.3 million in Q4 2025.
Vericel (VCEL) Operating Leases (2019 - 2026) Analysis & Trends
Vericel has disclosed Operating Leases across 8 years of filings, most recently posting $95.0 million for Q1 2026.
- Operating Leases for Q1 2026 came in at $95.0 million, up 8.24% year-over-year; the trailing twelve-month figure through Mar 2026 was $95.0 million (up 8.24% YoY), and the FY2025 annual result was $82.3 million, down 8.16% from the prior year.
- Operating Leases came in at $95.0 million for Q1 2026 at Vericel, up from $82.3 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $100.4 million in Q2 2025 to a low of $43.3 million in Q4 2022.
- The 5-year median for Operating Leases is $84.2 million (2025), against an average of $76.4 million.
- Across the five-year window, Operating Leases jumped 89.18% in 2023 and fell 13.65% in 2025, its largest moves.
- Vericel's Operating Leases stood at $43.3 million in 2022, then surged by 89.18% to $81.9 million in 2023, then rose by 9.45% to $89.6 million in 2024, then slipped by 8.16% to $82.3 million in 2025, then rose by 15.5% to $95.0 million in 2026.
- The last three Operating Leases figures came in at $95.0 million (Q1 2026), $82.3 million (Q4 2025), and $84.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Vericel | 2.04 Bn | 1.90 Bn | 49.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 95.04 Mn |
| Dec 31, 2025 | 82.28 Mn |
| Sep 30, 2025 | 84.16 Mn |
| Jun 30, 2025 | 100.44 Mn |
| Mar 31, 2025 | 87.80 Mn |
| Dec 31, 2024 | 89.59 Mn |
| Sep 30, 2024 | 97.46 Mn |
| Jun 30, 2024 | 95.59 Mn |
| Mar 31, 2024 | 86.14 Mn |
| Dec 31, 2023 | 81.86 Mn |
| Sep 30, 2023 | 85.00 Mn |
| Jun 30, 2023 | 83.38 Mn |
| Mar 31, 2023 | 46.88 Mn |
| Dec 31, 2022 | 43.27 Mn |
| Sep 30, 2022 | 48.12 Mn |
| Jun 30, 2022 | 44.96 Mn |
| Mar 31, 2022 | 46.05 Mn |
| Dec 31, 2021 | 47.15 Mn |
| Sep 30, 2021 | 48.54 Mn |
| Jun 30, 2021 | 46.93 Mn |